High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients
Main Authors: | Rachner, Tilman D, Thiele, Stefanie, Göbel, Andy, Browne, Andrew, Fuessel, Susanne, Erdmann, Kati, Wirth, Manfred P, Fröhner, Michael, Todenhöfer, Tilman, Muders, Michael H, Kieslinger, Matthias, Rauner, Martina, Hofbauer, Lorenz C |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167148/ |
Similar Items
-
Dickkopf-1 is regulated by the mevalonate pathway in breast cancer
by: Rachner, Tilman D, et al.
Published: (2014) -
Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin
by: Benad-Mehner, Peggy, et al.
Published: (2013) -
p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells
by: Browne, A J, et al.
Published: (2016) -
Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
by: Todenhöfer, Tilman, et al.
Published: (2015) -
RANKL/OPG in Breast Cancer — Extending Its Territory to BRCA Mutation Carriers
by: Rachner, Tilman D., et al.
Published: (2015)